Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
- Cancer
- Concussions
- CRISPR
- Drug Pricing
- End of Life
- Health Disparities
- Immigration
- Opioids
- Trump
- Women’s Health
- Zika
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

21st Century Cures Act

Pharmalot

Pharmalot, Pharmalittle: Is the 21st Century Cures bill in doubt over drug prices?

By Ed Silverman

Politics

Senate delays Cures bill, as window for major legislation narrows

By David Nather

advertisement

Politics

Landmark effort to speed drug approvals nears critical phase in Congress

By David Nather

advertisement

Politics

Republicans seize on reports critiquing FDA to push for agency reforms

By Sheila Kaplan

The Pharmalot View

Why we shouldn’t trade a weakened FDA for more medical research funds

By Ed Silverman

Exclusive

Public wary of faster approvals of new drugs, STAT-Harvard poll finds

By David Nather and Sheila Kaplan

Politics

Fight over NIH funding puts Senate medical innovation bills in jeopardy

By Sheila Kaplan

advertisement

Politics

With comprehensive legislation stalled, Senate panel clears 7 smaller biomed bills

By Sheila Kaplan

advertisement

Politics

Partisan split threatens progress on bill to speed drug approvals

By Sheila Kaplan

Pharmalot

A case for taking risks on drugs for the dying

By Ed Silverman

Politics

Michael Milken, from junk bonds to legislative advocate

By Sheila Kaplan

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT